NCNA
NuCana plc American Depositary Share
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
NuCana (NCNA) Stock: Buy, Sell, or Hold?
$0.93
-0.01 (-1.04%)
▼
5d:
-0.43%
30d:
-11.43%
90d:
-41.51%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (58%)
Quality Score
41/100
Position
OVERSOLD
30-Day Fair Range
$0.96 – $1.08
Position: OVERSOLD
Forward P/E & Valuation
-17.9x
Next 12M consensus est.
Wall Street Target
$104.00
+11082.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.88 / $1.09
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: NCNA shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When NCNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NCNA is currently trading at $0.93, which is considered oversold relative to its 30-day fair value range of $0.96 to $1.08.
Technical Outlook: Technically, NCNA is in a strong downtrend. Immediate support is located at $0.88, while resistance sits at $1.09.
Market Sentiment: NCNA scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $104.00 (+11082.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NCNA is in a strong downtrend. Immediate support is located at $0.88, while resistance sits at $1.09.
Market Sentiment: NCNA scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $104.00 (+11082.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.96 -
$1.08
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Trading Range & Key Levels
30-Day Trading Range
$0.96 -
$1.08
Current vs Trading Range
OVERSOLD
Support Level
$0.88
Resistance Level
$1.09
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (29/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 11082.8% below Wall St target ($104.00)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-17.88
Wall Street Target
$104.00
(+11082.8%)
Share NCNA Analysis
Share this live NCNA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NCNA)
Bearish
1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Sep 10, 2025
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on NCNA are bearish (sentiment score +0.00) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:52 AM ET
Data refreshes hourly during market hours. Next update: 6:52 AM
Data refreshes hourly during market hours. Next update: 6:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NCNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 64 BUY |
|
STRO
Sutro Biopharma |
STRONG BUY
14 analysts |
$47 | 58 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 42 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NCNA Research Pages
